Cefluprenam is a fourth generation cephalosporin. It was patented in 2008 by now defunct Cubist Pharmaceuticals. A 1997 clinical trial illustrated that Cefluprenam is highly effective against bacterial pneumonia.
Cefluprenam is a fourth generation cephalosporin. It was patented in 2008 by now defunct Cubist Pharmaceuticals. A 1997 clinical trial illustrated that Cefluprenam is highly effective against bacterial pneumonia.
==References==
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).